Inotuzumab ozogamicin (InO) is an antibody drug conjugate composed of a humanized
monoclonal antibody targeting the cell surface receptor CD22 coupled to a cytotoxic …

Introduction Bone marrow transplantation (BMT) is the standard treatment for several
hematologic pathologies. Post-BMT patients may develop hepatobiliary complications that …

The current incidence, diagnostic policy, management, and outcome of VOD/SOS at EBMT
centers were studied. All centers that had performed allogeneic HSCTs in adult patients …

Background Transplant‐associated thrombotic microangiopathy (TA‐TMA) is an endothelial
injury complication of hematopoietic stem cell transplant (HSCT) leading to end‐organ …

(1) Background: Acute kidney injury (AKI) is a serious complication of hematopoietic stem
cell transplantation (HSCT).(2) Methods: The aim was to identify the incidence, severity, and …

Hematopoietic cell transplant (HCT) recipients are at risk for thromboembolic and bleeding
complications. There is limited evidence regarding the optimal approach to managing …

Severe hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a
potentially life-threatening complication of haematopoietic cell transplantation (HCT). This …

BACKGROUND Currently, no laboratory tests exist to stratify for the risk of developing
sinusoidal obstruction syndrome (SOS), an early endothelial complication after …

Allogeneic hematopoietic cell transplantation (alloHCT) is indicated for patients with
intermediate-risk or high-risk myelofibrosis (MF) and remains the sole potential cure …

COVID-19, the syndrome caused by the infection with SARS-CoV-2 coronavirus, is
characterized, in its severe form, by interstitial diffuse pneumonitis and acute respiratory …